Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment

    December 2025 in “ Clinical and Translational Science ”
    Tvisha Devireddy, Chang-Sup Lim, Jhillika Patel … Bernard A. Cohen
    Studysummary This review highlights that chemotherapy-induced skin toxicities from EGFR inhibitors in breast cancer treatment can significantly impact patient quality of life and treatment adherence, emphasizing the importance of proactive management and patient discussions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. The Incidence and Management of Cutaneous Adverse Events of the Epidermal Growth Factor Receptor Inhibitors Postępy Dermatologii i Alergologii · 2017